166 related articles for article (PubMed ID: 33661574)
1. Preoperative plasmapheresis in patients with Graves' disease intolerant to antithyroid drugs.
Apaydin T; Gogas Yavuz D
Ther Apher Dial; 2021 Dec; 25(6):877-883. PubMed ID: 33661574
[TBL] [Abstract][Full Text] [Related]
2. Preoperative plasmapheresis experience in Graves' disease patients with anti-thyroid drug-induced hepatotoxicity.
Apaydın T; Elbasan O; Yavuz DG
Transfus Apher Sci; 2020 Oct; 59(5):102826. PubMed ID: 32532690
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of preoperative therapeutic plasma exchange in patients with hyperthyroidism and factors affecting the number of sessions.
Durmuş ET; Atmaca A; Özatlı D; Çolak R; Durmuş B
Endocrine; 2022 Apr; 76(1):101-108. PubMed ID: 35094312
[TBL] [Abstract][Full Text] [Related]
4. Effect of antithyroid drugs on the occurrence of antibodies against type 2 deiodinase (DIO2), which are involved in hyperthyroid Graves' disease influencing the therapeutic efficacy.
Molnár I; Szentmiklósi JA; Gesztelyi R; Somogyiné-Vári É
Clin Exp Med; 2019 May; 19(2):245-254. PubMed ID: 30610492
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic plasma exchange in hyperthyroidism prior to surgery.
Kirkizlar HO; Celik M
J Endocrinol Invest; 2023 Jan; 46(1):173-179. PubMed ID: 35963982
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Plasmapheresis Enabling Radioactive Iodine Treatment in a Patient with Thyrotoxicosis.
Min SH; Phung A; Oh TJ; Han KS; Kim MJ; Kim JM; Lee JH; Park YJ
J Korean Med Sci; 2015 Oct; 30(10):1531-4. PubMed ID: 26425054
[TBL] [Abstract][Full Text] [Related]
7. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
[TBL] [Abstract][Full Text] [Related]
8. Preoperative therapeutic plasma exchange in patients with thyrotoxicosis.
Ezer A; Caliskan K; Parlakgumus A; Belli S; Kozanoglu I; Yildirim S
J Clin Apher; 2009; 24(3):111-4. PubMed ID: 19484727
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic plasmapheresis in patients with severe hyperthyroidism in whom antithyroid drugs are contraindicated.
Ozbey N; Kalayoglu-Besisik S; Gul N; Bozbora A; Sencer E; Molvalilar S
Int J Clin Pract; 2004 Jun; 58(6):554-8. PubMed ID: 15311553
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema.
Bilir BE; Atile NS; Kirkizlar O; Kömürcü Y; Akpinar S; Sezer A; Demir M; Hekimoğlu S
Gynecol Endocrinol; 2013 May; 29(5):508-10. PubMed ID: 23383744
[TBL] [Abstract][Full Text] [Related]
11. Role of plasma exchange in autoimmune hyperthyroidism complicated by severe tiamazol-induced cholestatic jaundice.
Miljić D; Stojanović M; Ješić R; Bogadnović G; Popović V
Transfus Apher Sci; 2013 Oct; 49(2):354-6. PubMed ID: 23756266
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Plasma Exchange as a Bridging Therapy for the Definitive Treatment of a Patient with Graves' Disease and Methimazole-Induced Liver Injury.
Purnamasari D; Wildan A; Kurniawan J; Mulansari NA; Karim B; Danil Yulian E
Int J Endocrinol Metab; 2023 Jul; 21(3):e136608. PubMed ID: 38028251
[TBL] [Abstract][Full Text] [Related]
14. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
Okamura K; Bandai S; Fujikawa M; Sato K; Kitazono T
Endocr J; 2020 Jul; 67(7):751-758. PubMed ID: 32238669
[TBL] [Abstract][Full Text] [Related]
16. Successful preoperative treatment of a Graves' disease patient with agranulocytosis and hemophagocytosis using double filtration plasmapheresis.
Lew WH; Chang CJ; Lin JD; Cheng CY; Chen YK; Lee TI
J Clin Apher; 2011; 26(3):159-61. PubMed ID: 21268097
[TBL] [Abstract][Full Text] [Related]
17. The Long-Term Outcome of Treatment for Graves' Hyperthyroidism.
Sjölin G; Holmberg M; Törring O; Byström K; Khamisi S; de Laval D; Abraham-Nordling M; Calissendorff J; Lantz M; Hallengren B; Filipsson Nyström H; Wallin G
Thyroid; 2019 Nov; 29(11):1545-1557. PubMed ID: 31482765
[No Abstract] [Full Text] [Related]
18. Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication.
Kadmon PM; Noto RB; Boney CM; Goodwin G; Gruppuso PA
J Clin Endocrinol Metab; 2001 May; 86(5):1865-7. PubMed ID: 11344172
[TBL] [Abstract][Full Text] [Related]
19. Management of Graves Disease: A Review.
Burch HB; Cooper DS
JAMA; 2015 Dec; 314(23):2544-54. PubMed ID: 26670972
[TBL] [Abstract][Full Text] [Related]
20. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
